10 Biotech Stocks Expected to at Least Double

by Web Master, Benzinga Editor
October 19, 2010 6:30 AM | 6 seconds read |
The following 10 biotech stocks, though exceptionally risky, are expected to double, triple or quadruple in the next 12 months.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!